The 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responses (original) (raw)
Brendon Coventry2012, Cancer Management and Research
visibility
…
description
7 pages
link
1 file
Related papers
Interleukin 2 receptor—A target for immunosuppressive therapy
Transplantation Reviews, 1987
Interleukin-2 Tickles T Cell Memory
Immunity, 2010
Cancer Treatment Reviews, 1989
Cancer Immunology Immunotherapy, 1993
IL-2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells
European Journal of Immunology, 2008
American Journal of Transplantation, 2002
Thrombocytopenia during immunotherapy with interleukin-2 by constant infusion
The American Journal of Medicine, 1990
The dark side of immunotherapy
Annals of Translational Medicine, 2021
Immunotherapy/Biological Therapies
Neuro-Oncology, 2013
Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays
BMC Immunology, 2009
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
Related papers
Journal of Clinical Investigation, 1993
Forecasting the cytokine storm following systemic interleukin (IL)-2 administration
Journal of translational medicine, 2004
Cytokines and anti-cytokines as therapeutics — An update
European Journal of Pharmacology, 2008
The Value of Inflammatory Signals in Adaptive Immune Responses
Lecture Notes in Computer Science, 2011
Human Interleukin 2 (IL-2) Promotion of Immune Regulation and ClinicalOutcomes: A Review
Claudia Regina Bonini Domingos
Journal of Cytokine Biology, 2016
The Journal of Immunology, 2013
A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapy
OncoImmunology, 2020
Cytokines with Possible Clinical Utility
… new results in …, 1987
Molecular Cloning of cDNA for the Human Interleukin-2 Receptor
Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, 1985
The transition from acute to chronic inflammation
British Journal of Dermatology, 1985
Pharmacologic Administration of Interleukin-2
Annals of the New York Academy of Sciences, 2009
Clin-Immunotherapy/Biologic Therapies
Neuro-Oncology, 2012
Inflammation at the interface of Innate and Acquired Immunity
Molecular Immunology, 2009
Immunosuppression: Evolution in Practice and Trends, 1994–2004
American Journal of Transplantation, 2006
Pharmacokinetics of recombinant interleukin 2 in humans
Cancer research, 1990
Pharmacokinetics and stability of the ch14.18-interleukin-2 fusion protein in mice
Cancer Immunology, Immunotherapy, 1999
24. Clinical and laboratory assessment of immunity
Journal of Allergy and Clinical Immunology, 2003
Effects of interleukin-2 in immunostimulation and immunosuppression
The Journal of Experimental Medicine, 2019
The 2nd International standard for Interleukin-2 (IL-2) Report of a collaborative study
Journal of Immunological Methods, 2013
Cancer Immunology Immunotherapy, 1993
Molecular and Cellular Biology, 1994
Efficacy Than Wild Type IL-2 Human IL-2 Mutein with Higher Antitumor
2013
Distinct Clinical and Laboratory Activity of Two Recombinant Interleukin-2 Preparations
Clinical Cancer Research, 1999
Focus on FOCIS: Interleukin 2 treatment associated autoimmunity
Clinical Immunology, 2008
Immunotherapy: breakthrough in Cancer Treatment
2023